REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

SELECTIS HEALTH, INC. ($GBCS)

Sector: Healthcare Facilities  •  Exchange / CIK: OTC / 0000727346  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$5.73
52W Range: $1.50 - $5.83

Valuation Multiples

14.0x P/AFFO
P/FFO: 13.0x  |  FFO/sh: $0.44

Net Asset Value (NAV)

$6.25
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.58% Yield
$0.32/yr (Quarterly)  |  Payout: 78.0%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.0800 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
SELECTIS HEALTH, INC. Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $937,500,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.04
Defensive (Low Sensitivity)
Annualized Alpha (α)
+38.78%
Outperforming VNQ
Sharpe Ratio (vs VNQ)
1.6 vs -4.25
+5.85 Spread
Max Drawdown (1-Yr)
-6.2% vs -10.9%
+4.7% vs VNQ
GBCS vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric GBCS VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.04 1.00 -0.96 (Defensive (Low Sensitivity))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
+38.78% 0.00% (Baseline) Outperforming VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
1.6 -4.25 +5.85
Sortino Ratio
Downside semi-variance risk-adjusted return
1.81 -4.52 +6.33
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
20.4% 11.3% +9.1% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-6.2% -10.9% +4.7% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
42.1% -35.6% +77.7% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.0 Corr: 0.02 0% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
23.2% 30.4% -7.2% vs Benchmark
QuantStats Analytical Synthesis: GBCS displays a Beta of 0.04 relative to VNQ with 0.00 R² correlation. Annualized volatility is 20.4% (9.2% higher than VNQ at 11.3%). Trailing 12-month Alpha stands at +38.78% (Outperforming VNQ) with a Sharpe ratio of 1.60 against -4.25 for VNQ, and a maximum drawdown of -6.2%.
SEC CIK: 0000727346  |  Principal Executive Officer: Executive Leadership / SELECTIS Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0000727346-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.